Diet and Body Composition (CENTRAL)

October 21, 2020 updated by: Iris Shai, Ben-Gurion University of the Negev

Effect of Weight-loss Diet Strategies and Exercise on Dynamics of Body Fat Depots and Metabolic Rate

The investigators hypothesize that differential dynamics in fat depots in response to two opposing dietary strategies mediate the beneficial metabolic effects during weight loss and regain phases.

Study Overview

Study Type

Interventional

Enrollment (Actual)

224

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dimona, Israel
        • nuclear research center Negev

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Elevated waist circumference:

    • Men: > 40 inches (102 cm)
    • Women> 35 inches (88 cm)
  • Poor dieters with TG>150mg/dL and high-density-lipoprotein cholesterol [HDL-c] <40 mg/dL for men and <50 mg/dL for women

Exclusion Criteria:

  • Pregnant or lactating women
  • Serum creatinine LT 2 mg/dl
  • Disturbed liver function (LT 3 fold level of ALT and AST enzymes)
  • Active cancer
  • Individuals who cannot start physical activity in the gym
  • Individuals that are highly physically active (more than 4 hours/week)
  • Active in other nutritional trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: low fat diet
Weight-loss diet strategy
Weight-loss diet strategy with a free gym membership; monthly 60-minute educational workshops; 3 sessions of workout per week of mostly aerobic training
Weight-loss diet strategy without exercise
Experimental: low carb diet
Weight-loss diet strategy
Weight-loss diet strategy with a free gym membership; monthly 60-minute educational workshops; 3 sessions of workout per week of mostly aerobic training
Weight-loss diet strategy without exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
body fat composition
Time Frame: 0, 6,18 months
changes in body fat (MRI)
0, 6,18 months
obesity
Time Frame: 0, 6, 18 months
changes in weight
0, 6, 18 months
abdominal obesity
Time Frame: 0, 6, 18 months
changes in waist circumference
0, 6, 18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lipid profile
Time Frame: 0, 6, 18 months
Changes in lipid biomarkers: total cholesterol (mg/dL), triglycerides (mg/dL), HDLc (mg/dL), LDLc (mg/dL) (blood draw)
0, 6, 18 months
Glycemic control
Time Frame: 0, 6, 18 months
Changes in fasting glucose (mg/dL) (blood draw)
0, 6, 18 months
Glycemic control
Time Frame: 0, 6, 18 months
Changes in insulin (μIU/mL) (blood draw)
0, 6, 18 months
Inflammatory state
Time Frame: 0, 6, 18 months
Changes hsCRP (mg/L) (blood draw)
0, 6, 18 months
Metabolomic
Time Frame: 0, 6, 18 months
Changes in sub-lipids (blood draw)
0, 6, 18 months
Metabolomic
Time Frame: 0, 6, 18 months
Changes in sub-proteins ( blood draw)
0, 6, 18 months
Liver function (blood biomarkers)
Time Frame: 0, 6, 18 months
Changes in ALT (U/l), AST (U/l), ALKP (U/I), GGT (U/l) (blood draw)
0, 6, 18 months
Genetic signature
Time Frame: baseline
SNPs (variants) associated with fat distribution and visceral fat (blood draw)
baseline
Epigenetics
Time Frame: 0, 6, 18 months
changes in genes' methylation (blood draw)
0, 6, 18 months
Epigenetics
Time Frame: 0, 6, 18 months
changes in mRNAs (blood draw)
0, 6, 18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2012

Primary Completion (Actual)

April 1, 2014

Study Completion (Actual)

April 1, 2014

Study Registration Dates

First Submitted

February 8, 2012

First Submitted That Met QC Criteria

February 9, 2012

First Posted (Estimate)

February 10, 2012

Study Record Updates

Last Update Posted (Actual)

October 23, 2020

Last Update Submitted That Met QC Criteria

October 21, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • ISF256/09
  • 256/09 (Other Grant/Funding Number: ISF256/09)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Weight-loss diet strategy (+) exercise (PA)

Subscribe